SYDNEY, Australia, 18 November 2020 – Vitex Pharmaceuticals is going ahead with its plans to build two new facilities in the new Western Parkland City – an Advanced Manufacturing Research Academy and a Pharmaceutical Manufacturing Facility. This will create over a thousand jobs and train hundreds of students in pharmaceutical manufacturing.
Minister for Jobs, Investment, Tourism and Western Sydney Stuart Ayres has welcomed this development and acknowledged the “scale and success of this home-grown company” and “their proposed multi-million dollar investment” in the new Aerotropolis.
“The Institute will be the first in Australia to offer dedicated training in pharmaceutics and the pharmaceutical process engineering which is a current major skills gap in our industry. In doing so, we hope to not only raise the skills of our own people, but also contribute to raising the standard of our industry in Australia,” said Dr Aniss Chami, CEO, Vitex Pharmaceuticals.
Dr Chami reiterated the importance of upholding the premium quality reputation of Australian manufacturing whilst maintaining speed to market. “In investing in a second Pharmaceutical Facility within the Aerotropolis, we continue to remain steadfast in our commitment to supplying high quality Australian made pharmaceutical products to the world,” concluded Dr Chami.
Please click for full details of the Media Release by Minister Ayres.
About Vitex Pharmaceuticals
Vitex Pharmaceuticals is a leading contract manufacturer of Australian-made vitamins, supplements and wellness products. From its 26,000sqm best-in-class facility in Sydney, Australia, Vitex is fully equipped to formulate, manufacture and package a wide variety of vitamins, minerals, herbal and nutritional supplements including tablets, soft gel capsules, two-piece hard gel capsules and powders.